Evidence mapPaperPMID 30890971Full record

ReviewFrontiers in psychiatry2019

Statins and Inflammation: New Therapeutic Opportunities in Psychiatry.

Sung-Wan Kim, Hee-Ju Kang, Min Jhon, Ju-Wan Kim, Ju-Yeon Lee, Adam J Walker, Bruno Agustini, Jae-Min Kim, Michael Berk

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 3 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 3 syntheses or guidelines pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Observational
  7. Article
  8. 2025 Egyptian guidelines for the management of dyslipidemia.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026
    Review
  9. Article
  10. Article
  11. Bioactive Properties ofFoods (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Observational
  14. Review
  15. Article
  16. Saturated fat in an evolutionary context.Lipids in health and disease · 2025
    Review
  17. Review
  18. Article
  19. Review
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sung-Wan KimDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.
Hee-Ju KangDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.
Min JhonDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.
Ju-Wan KimDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.
Ju-Yeon LeeDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.
Adam J WalkerIMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia.
Bruno AgustiniIMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia.
Jae-Min KimDepartment of Psychiatry, Chonnam National University Medical School, Gwangju, South Korea.
Michael BerkIMPACT Strategic Research Centre, School of Medicine, Deakin University, Geelong, VIC, Australia.
Chonnam National University Hospital · KRDeakin University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and anti-oxidant effects. These are thought to be responsible for the potential effects of statins on various psychiatric disorders. In this study, we comprehensively review the literature to investigate the effects of statins on various psychiatric disorders including depression, schizophrenia, and dementia. In addition, we review adverse effects and drug interactions of statins to give clinically useful information guiding statin use in the psychiatric field. Statins seem useful in reducing depression, particularly in patients with physical disorders such as cardiovascular disease. In patients with schizophrenia, negative symptoms may be reduced by adjuvant statin therapy. Studies on cohorts at risk for dementia have generally shown protective effects of statins, while those on treatment for dementia show inconsistent results. In conclusion, statins used in combination with conventional psychotropic medications may be effective for various psychiatric disorders including depression, schizophrenia, and dementia. Further study is required to determine optimal doses and duration of statin use for the treatment of psychiatric disorders.

Indexed as

dementiadepressioninflammationschizophreniastatin

Identifiers

PMID30890971
PMCPMC6413672
OpenAlexW2916641014

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.